Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Must-Have Cooking Machine in Your Kitchen - 2The Job of Attorneys: It is Important to Comprehend When Legitimate Help
- 3Dominating Monetary Administration: A Bit by bit Manual for Making an Individual Financial plan
- 4Remote Headphones: Upgrade Your Sound Insight
- 5Vote In favor of Your Favored Language Learning Applications
- Best bar-b-que Style: Which One Is Your #1?
- Exploiting Unsold Rams: May Be Less expensive Than You Suspect
- She was moments away from giving birth. The hospital discharged her
- Misremembering might actually be a sign your memory is working optimally
- Mating injuries may lead scientists to identify dinosaurs’ sex
- Defense Minister Katz moves to extend IDF service to 36 months
- Public Parks in the USA
- New movies to watch this weekend: See 'The Running Man' in theaters, rent 'One Battle After Another,' stream 'Nobody 2' on Peacock
- The capacity to understand people on a profound level: Exploring Life's Intricacies
